Chloroquine nasal drops in asymptomatic & mild COVID-19: An exploratory randomized clinical trial

BACKGROUND & OBJECTIVES: Chloroquine (CQN) administered as nasal drops has the potential to achieve much greater local tissue levels than with oral/systemic administration. This trial was undertaken to study the efficacy and safety profile of topical nasal administration of CQN drops in reducing...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakar, Alok, Panda, Smriti, Sakthivel, Pirabu, Brijwal, Megha, Dhakad, Shivram, Choudekar, Avinash, Kanodia, Anupam, Bhatnagar, Sushma, Mohan, Anant, Maulik, Subir K., Dar, Lalit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184066/
https://www.ncbi.nlm.nih.gov/pubmed/33818472
http://dx.doi.org/10.4103/ijmr.IJMR_3665_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184066/
https://www.ncbi.nlm.nih.gov/pubmed/33818472
http://dx.doi.org/10.4103/ijmr.IJMR_3665_20

Ejemplares similares